GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Ningbo Sanxing Medical Electric Co 601567.SS · CNY

Industrials · Shanghai · 🇨🇳 China

Compare

12.36

-1.98%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥14.36bn

FY2016FY2025

Net income

CN¥1.27bn

FY2016FY2025

Free cash flow

CN¥831.9m

FY2016FY2025

Shareholders' equity

CN¥11.53bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥14.36bnCN¥14.60bnCN¥11.46bnCN¥9.10bnCN¥7.02bnCN¥7.09bnCN¥6.81bnCN¥5.87bnCN¥5.37bnCN¥4.92bn
Gross profitCN¥4.02bnCN¥5.02bnCN¥3.86bnCN¥2.61bnCN¥1.76bnCN¥2.03bnCN¥1.95bnCN¥1.70bnCN¥1.79bnCN¥1.61bn
Research and developmentCN¥607.3mCN¥523.3mCN¥470.8mCN¥327.0mCN¥294.0mCN¥312.8mCN¥325.0mCN¥268.0mCN¥205.9mCN¥178.0m
Operating incomeCN¥1.61bnCN¥2.63bnCN¥2.27bnCN¥1.15bnCN¥851.2mCN¥1.19bnCN¥1.21bnCN¥640.7mCN¥891.6mCN¥735.1m
Net incomeCN¥1.27bnCN¥2.26bnCN¥1.90bnCN¥948.1mCN¥690.0mCN¥956.1mCN¥1.00bnCN¥508.1mCN¥890.6mCN¥794.2m
Diluted earnings per share0.921.611.370.680.510.700.760.350.620.56

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥25.79bnCN¥24.48bnCN¥21.51bnCN¥16.23bnCN¥14.87bnCN¥13.70bnCN¥13.61bnCN¥14.32bnCN¥12.71bnCN¥11.64bn
Cash and short-term investments—CN¥5.37bnCN¥5.51bnCN¥2.96bnCN¥3.08bnCN¥2.60bnCN¥2.09bnCN¥1.97bnCN¥1.58bnCN¥3.05bn
Total liabilitiesCN¥14.01bnCN¥12.20bnCN¥10.36bnCN¥6.61bnCN¥5.93bnCN¥4.91bnCN¥5.53bnCN¥6.82bnCN¥5.13bnCN¥4.71bn
Debt—CN¥5.22bnCN¥4.37bnCN¥2.06bnCN¥2.41bnCN¥2.04bnCN¥1.76bnCN¥2.11bnCN¥2.15bnCN¥1.87bn
Shareholders' equityCN¥11.53bnCN¥12.08bnCN¥11.01bnCN¥9.51bnCN¥8.87bnCN¥8.62bnCN¥8.04bnCN¥7.46bnCN¥7.52bnCN¥6.85bn
Shares outstanding1,391m1,400m1,392m1,387m1,350m1,369m1,324m1,467m1,441m1,424m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥1.77bnCN¥1.84bnCN¥1.90bnCN¥1.22bnCN¥198.9mCN¥1.23bnCN¥924.6mCN¥445.0mCN¥933.5mCN¥881.8m
Capital spending−CN¥939.5m−CN¥1.04bn−CN¥555.9m−CN¥403.9m−CN¥295.2m−CN¥206.4m−CN¥184.0m−CN¥316.5m−CN¥216.0m−CN¥280.6m
Free cash flowCN¥831.9mCN¥791.6mCN¥1.35bnCN¥818.7m−CN¥96.3mCN¥1.02bnCN¥740.6mCN¥128.5mCN¥717.5mCN¥601.3m
Dividends paid−CN¥1.99bn−CN¥953.1m−CN¥512.1m−CN¥450.8m−CN¥485.3m−CN¥291.2m−CN¥416.0m−CN¥685.5m−CN¥614.3m−CN¥136.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥4.03bnCN¥3.24bnCN¥3.28bnCN¥3.11bnCN¥4.34bnCN¥3.63bnCN¥4.17bnCN¥3.44bn
Gross profitCN¥992.8mCN¥810.0mCN¥862.0mCN¥843.6mCN¥1.22bnCN¥1.05bnCN¥1.24bnCN¥1.37bn
Operating incomeCN¥385.3mCN¥232.8mCN¥184.3mCN¥122.1mCN¥587.0mCN¥567.1mCN¥508.5mCN¥761.1m
Net incomeCN¥378.5mCN¥167.3m−CN¥253.9mCN¥298.1mCN¥740.4mCN¥489.3mCN¥443.8mCN¥665.7m
Diluted earnings per share0.270.12-0.180.210.530.350.320.48
Cash from operations———CN¥545.0mCN¥89.0m−CN¥144.0m—CN¥800.0m
Capital spending−CN¥167.0m−CN¥127.0m−CN¥331.0m−CN¥104.0m−CN¥229.0m−CN¥273.0m−CN¥334.0m−CN¥322.0m
Free cash flow———CN¥441.0m−CN¥140.0m−CN¥417.0m—CN¥478.0m
Total assetsCN¥23.49bnCN¥25.36bnCN¥25.79bnCN¥24.16bnCN¥23.25bnCN¥24.53bnCN¥24.48bnCN¥21.31bn
Cash and short-term investments———CN¥3.08bnCN¥2.80bnCN¥5.04bnCN¥5.37bnCN¥2.65bn
DebtCN¥822.5mCN¥4.75bnCN¥5.07bnCN¥2.48bnCN¥1.05bnCN¥2.89bnCN¥3.18bnCN¥545.0m
Shareholders' equityCN¥11.73bnCN¥11.69bnCN¥11.53bnCN¥12.42bnCN¥12.16bnCN¥12.59bnCN¥12.08bnCN¥11.70bn

Financial ratios

Data as of 19 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin28.0%34.4%33.7%28.7%25.1%28.6%
Operating margin11.2%18.0%19.8%12.7%12.1%16.8%
Net margin8.9%15.5%16.6%10.4%9.8%13.5%
Return on equity11.1%18.7%17.3%10.0%7.8%11.1%
Return on assets4.9%9.2%8.8%5.8%4.6%7.0%
Free cash flow yield13.7%14.4%12.4%8.2%2.6%7.4%
Revenue growth-1.6%27.4%26.0%29.6%-1.0%4.2%
Earnings growth-43.6%18.7%100.8%37.4%-27.8%-4.8%
Current ratio1.88x1.77x1.78x1.45x1.63x1.60x
Debt to equity0.44x0.26x0.22x0.09x0.19x0.15x
Equity ratio44.7%49.4%51.2%58.6%59.7%62.9%
Interest coverage12.95x21.49x43.04x14.61x9.40x32.03x
R&D as a share of sales4.2%3.6%4.1%3.6%4.2%4.4%
Buybacks as a share of market value0.6%-0.6%-0.4%-2.7%1.4%-3.4%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue16.4%15.2%13.2%
Operating income11.8%6.2%9.7%
Net income10.3%5.9%8.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin31.2%31.3%30.3%30.6%
Operating margin14.7%15.5%15.3%15.2%
Net margin12.2%12.9%12.6%13.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings25.219.115.019.731.99.59.816.315.720.6
Price to sales2.23.02.52.03.11.31.41.42.63.3

Dividends and splits

Per share, in the currency the company pays

Paid for 9 years. Last went ex-dividend on 20 Oct 2025.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year1.3750.650.350.320.350.210.300.30
  • 5-for-2 split · 17 Jun 2015
  • 3-for-2 split · 29 Jun 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.